Lee et al. found that HMGB1 was highly expression in TNBC by using patient tissues and immunohistochemistry, and the expression of HMGB1 was notably correlated with tissue grade, abundant tumor infiltrating lymphocytes and CD8 positive cells. This evidence concerns the gene CD8A and neoplasm.